PDCD1 and neoplasm: Studies have reported that the programmed death‐ligand 1 (PD‐L1) positivity rate, or tumour proportion score, can partially predict the responses to PD‐1 or PD‐L1 drugs,137 but there is no consensus among clinicians regarding this approach.